𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis

✍ Scribed by P. Rovel-Guitera; M-C. Diemert; J-L. Charuel; J-L. Laporte; L. Musset; O. Chosidow; J-C. Piette; C. Francès


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
219 KB
Volume
143
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Antineutrophil cytoplasmic antibodies (anca) of the iga isotype have, for the most part, been detected in patients with henoch-schönlein purpura (hsp) or inflammatory bowel disease.

Objectives:

We have evaluated the prevalence of iga anca in a series of patients with different causes of cutaneous vasculitis.

Methods:

Forty consecutive patients with histologically proven leucocytoclastic vasculitis were included in the study: 18 had systemic vasculitis as well as cutaneous lesions, 10 of whom were diagnosed as having hsp, and 22 had only cutaneous vasculitis (with no identified cause in 10 cases). iga anca were sought by indirect immunofluorescence using ethanol-fixed human neutrophil preparations as the substrate.

Results:

Iga anca were detected in six of 40 patients (15%) (one each with hsp, ulcerative colitis, sjögren's syndrome, hypergammaglobulinaemia associated with castelman's disease, erythema elevatum diutinum and bacterial endocarditis). three of these patients also had igg anca whose target antigen remained unidentified.

Conclusions:

Iga anca are rarely observed in hsp (10%) and can be detected in a wide variety of other cutaneous vasculitides.


📜 SIMILAR VOLUMES


Risk factors for relapse of antineutroph
✍ Michael Walsh; Oliver Flossmann; Annelies Berden; Kerstin Westman; Peter Höglund 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract ## Objective To determine the association between characteristics at diagnosis and the time to first relapse in a large cohort of patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). ## Methods We studied long‐term followup data from 4 clinical trials that i